K. Samitas (Athens, Greece), M. Adner (Stockholm, Sweden), M. Kurowski (Lódz, Poland), C. Taube (Essen, Germany)
Late Breaking Abstract - Title: Air-born allergens modulate the immunological lung microenvironment.
C. Afferni (Roma, Rm, Italy)
|  |
Activity of apoptotic and inflammatory caspases in THP-1 cells treated with extracellular Hsp70
A. Hulina (Brdovec, Croatia)
|  |
To explore mechanisms in obesity-associated asthma using functional proteomics technology: A pilot study
Z. Hongping (Chengdu, Sichuan, China)
| |
IL-27 and asthma endotypes- Is there a connection
K. Pabreja (Newcastle, NSW, Australia)
| |
Serum Vitamin D levels in patients with allergic rhinitis and fungal sensitisation
S. Kunal (DELHI (NEW DELHI), India)
| |
The role of vitamin D in severe asthma
F. De Castro Henriques De Lima (Póvoa de Varzim, Portugal)
| |
Correlation between plasma levels of IL-33 and Vitamin D in patients with severe uncontrolled allergic asthma
E. Janeva (Skopje, FYROM (Macedonia))
| |
Proteomics analysis of asthma biomarkers: proxima sub-study
P. Mauri (SEGRATE (MI), Italy)
| |
Apoptosis of lymphocytes in rhinal secretion of allergic rhinitis patients
O. Ukhanova (Stavropol, Russian Federation)
| |
Serum levels of IL-6 in adult patients with moderate to severe asthma.
D. Dimitrova (SOFIA, Bulgaria)
| |
Bronchiectasis disease relevant PAMPs stimulate VEGF and neutrophil elastase release from neutrophils
C. Cole (Middlesbrough, United Kingdom)
| |
The relationship of serum interleukin-13 to asthma control in a sample of nigerian asthmatics.
O. Awopeju (Ile-Ife, Osun State, Nigeria)
| |
The characteristics of production TNF-a according to the stage of interstitial lung diseases
M. Rakhimov (Samarkand, Uzbekistan)
| |
Clinical validation of Environmental Exposure Chamber in Strasbourg (ALYATEC®) with mite in asthmatic patients
I. CHOUAL (Strasbourg, France)
| |
Technical qualification of the Environmental Exposure Chamber of Strasbourg (ALYATEC®)
I. CHOUAL (Strasbourg, France)
| |
A naturalistic cat exposure chamber validation
S. Kelly (Ottawa, ON, Canada)
| |
Bronchoobstructive syndrome /BOS/ in the early childhood and asthma at six years of age
E. Georgieva (SOFIA, Bulgaria)
| |